What does CUSIP 14147L108 represent in this 13F holders report?

CUSIP 14147L108 is the security identifier for CRDF - Cardiff Oncology, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held CRDF - Cardiff Oncology, Inc. - Common Stock in Q2 2023?

50 institutional investors reported CRDF - Cardiff Oncology, Inc. - Common Stock for Q2 2023. Use the holders table for investor-level position and value details.

Cardiff Oncology, Inc. - Common Stock (CRDF)

CUSIP: 14147L108

Q2 2023 13F Holders as of 30 Jun 2023

Security type / class: Equity / Common Stock
Total 13F shares: 5,991,988
Total 13F value: $8,808,700
Share change: -1,057,731
Put/Call ratio: 0%
SEC-reported price per share: $1.47
Number of holders: 50
Value change: -$1,673,969
Number of buys: 13
Number of sells: 13
Shares outstanding: 66,404,538

Security key

14147L108

Report period

Q2 2023

Institutions

Top holders

CRDF full security history Ownership snapshot Full 13F holder table Cardiff Oncology, Inc. SEC filings Cardiff Oncology, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of CRDF - Cardiff Oncology, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

VANGUARD GROUP INC

Disclosed value leader

VANGUARD GROUP INC

Comparable rows

15/15

Latest evidence

31 Mar 2023

13F Lead comparable stake: 2.9% Showing 1-6 of 15 holder rows.

Quick read

VANGUARD GROUP INC leads the comparable SEC ownership view at 2.9%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens VANGUARD GROUP INC's linked filing trail.

Comparable ownership Top 5

VANGUARD GROUP INC 2.9%

BlackRock Finance, Inc. 1.1%

Laurion Capital Management LP 1.1%

CITIGROUP INC 0.98%

GEODE CAPITAL MANAGEMENT, LLC 0.62%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
VANGUARD GROUP INC	13F Company 13F	2.9%	$3,205,815 1,942,918 shares	—	31 Mar 2023
BlackRock Finance, Inc.	13F Company 13F	1.1%	$1,250,400 757,818 shares	—	31 Mar 2023
Laurion Capital Management LP	13F Company 13F	1.1%	$1,191,465 722,100 shares	—	31 Mar 2023
CITIGROUP INC	13F Company 13F	0.98%	$1,074,416 651,161 shares	—	31 Mar 2023
GEODE CAPITAL MANAGEMENT, LLC	13F Company 13F	0.62%	$682,278 413,502 shares	—	31 Mar 2023
Assenagon Asset Management S.A.	13F Company 13F	0.59%	$651,740 394,994 shares	—	31 Mar 2023

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

5,991,988

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders

Q2 2023 holders

Holder diff

-2

Investor	Q1 2023 Shares	Q2 2023 Shares	Share Diff	Share Chg %	Q1 2023 value	Q2 2023 value	Value change	Value Chg %